When was MediStrava founded?

MediStrava was founded in 2019.

Where is MediStrava located?

MediStrava is headquartered in London, United Kingdom.

How many employees does MediStrava have?

As of Jun 30, 2026, the latest employee count at MediStrava is 97.

Is MediStrava a funded company?

MediStrava is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does MediStrava rank among its competitors?

MediStrava ranks 49th amongst 105 active competitors, of which 13 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Tharimmune, which secured $545M in Nov, 2025.

Who are the top competitors of MediStrava?

MediStrava's top competitors include CancerVax, Tharimmune and OnCusp. Among them, Tharimmune secured the most recent funding round in November, 2025.

MediStrava - 2026 Company Profile, Team & Competitors

MediStrava is an unfunded company based in London (United Kingdom), founded in 2019. It operates as a Developer of therapies for treating chronic diseases. MediStrava has not raised any funding yet. The company has 105 active competitors, including 13 funded and 16 that have exited. Its top competitors include companies like CancerVax, Tharimmune and OnCusp.

Key Metrics

Founded Year

2019

Location

London, United Kingdom

Stage

Unfunded

Ranked

49^th among 105 active competitors

Employee Count

97 as on Jun 30, 2026

Investment & Acquisitions

MedEvoke

Similar Companies

CancerVax & 117 more

View MediStrava's full profile

MediStrava has not raised any funding rounds yet.

MediStrava's employee count trend

MediStrava has 97 employees as of Jun 26. Here is MediStrava's employee count trend over the years:

Uncover MediStrava's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MediStrava include CancerVax, Tharimmune and OnCusp. Here is the list of Top 10 competitors of MediStrava, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	CancerVax 1998, Carlsbad (United States), Series B	Limited information available	$58M	Athenian Venture Partners, endpointgroup.com ... & 11 others	48/100
2nd	Tharimmune 2023, Bridgewater (United States), Public	Clinical-stage biotechnology company developing a portfolio of therapeutic candidates for rare, inflammatory, and oncologic conditions	-	DRW Trading Group, Liberty City Ventures ... & 25 others	47/100
3rd	OnCusp 2021, New York City (United States), Series A	CRO offering clinical development services for oncology drugs	$139M	F-Prime Capital, Orbimed & 8 others	46/100
4th	Oncotherapeutics 1988, West Hollywood (United States), Acquired	CRO focused on community oncology research, improving cancer therapies' clinical utility	$8.3M	Domain Associates, TVM Capital	44/100
5th	Medivir 1998, Sweden, Public	Medivir - Science working wonders	-	-	41/100
6th	Vivia Biotech 2007, Tres Cantos (Spain), Series A	Developer of precision medicine test for hematologic cancers	$7.52M	Suanfarma, Clave	39/100
7th	Medelis 2003, Nashville (United States), Acquired	Oncology CRO providing expert clinical trial management for drug development	-	-	38/100
8th	EmeritusDX 2020, Irvine (United States), Unfunded	CRO focused on providing cancer drug development services	-	-	38/100
9th	Aster Insights 2006, Tampa (United States), Series C	Provider of contract based oncology clinical trial services	$75M	Clayton Dubilier & Rice, Hearst & 6 others	37/100
10th	Linical 2005, Osaka (Japan), Public	Full service CRO with presence in 20+ countries	-	Japan Asia Investment, SBIC West Japan	37/100
49th	MediStrava 2019, London (United Kingdom), Unfunded	Developer of therapies for treating chronic diseases	-	-	21/100